DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Racotumomab
Racotumomab
Estado Clínico-Oncológico De Pacientes Incluidos En El Ensayo Clínico RANIDO Tratados Con Racotumomab O Nimotuzumab
Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy
Racotumomab: an Anti-Idiotype Vaccine Related to N-Glycolyl-Containing Gangliosides – Preclinical and Clinical Data
Tables-Of-Phase-3-Mabs.Pdf
The Two Tontti Tudiul Lui Hi Ha Unit
CD20-Mimotope Peptides: a Model to Define the Molecular Basis Of
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
(INN) for Biological and Biotechnological Substances
Therapeutic Vaccines for Cancer: an Overview of Clinical Trials
Pertuzumab Panel Discussion Information
(INN) for Biological and Biotechnological Substances
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
Role of Immunotherapy in Ewing Sarcoma
Safety and Efficacy of Racotumomab-Alum Vaccine As Second-Line Therapy for Advanced Non-Small Cell Lung Cancer
Cancer and the Immune System: the Vital Connection
A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine As Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Single-Agent Maintenance Therapy for Advanced Non-Small Cell Lung Cancer
Top View
Racotumomab – a Novel Anti-Idiotype Monoclonal Antibody Vaccine for the Treatment of Cancer
Brentuximab Vedotin Guía De Revisión Rápida 2013
Vaccine and Immune Cell Therapy in Non-Small Cell Lung Cancer
Recent Advances in Nanotheranostics for Triple Negative Breast Cancer Treatment Vikram Thakur1 and Rajaletchumy Veloo Kutty2,3*
The Abcs of Clinical Trials in Cuba MEDICC Review, Vol
Immunoscintigraphy with 99Mtc-14F7 and 99Mtc
(12) United States Patent (10) Patent No.: US 9.295,731 B2 Nguyen (45) Date of Patent: Mar
PATIENT RESOURCE Monoclonal Antibodies
Targeting Selectins, Siglecs and Mammalian Glycans
Evaluación De Racotumomab Para El Tratamiento Del Cáncer De Pulmón: Meta-Análisis De Ensayos Controlados Del CIM
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
WO 2013/096791 Al 27 June 2013 (27.06.2013) P O P C T
Target Treatment and Symptoms Management
WO 2014/130879 A2 28 August 2014 (28.08.2014) P O P C T
Global Oncology Trend Report a Review of 2015 and Outlook to 2020
Novel Therapies for Relapsed and Refractory Neuroblastoma
WO 2017/096163 Al 8 June 2017 (08.06.2017) W P O P C T
Pilot Study of a Novel Combination of Two Therapeutic Vaccines in Advanced Non‑Small‑Cell Lung Cancer Patients